Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04669093 · ClinicalTrials.gov registry record · NA

Individual Differences in Placebo Analgesic Effects

A NA study, sponsored by Trustees of Dartmouth College.

Not yet
Registry status
NA
Development phase
60
Enrollment target

NCT04669093: Clinical Trial NA study, sponsored by Trustees of Dartmouth College.

NCT04669093 is a NA study that has not yet begun recruiting, run by Trustees of Dartmouth College. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04669093, a NA study, has not yet begun recruiting, sponsored by Trustees of Dartmouth College.

NOT YET RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study examines the effects of placebo suggestions tailored to match or mismatch individual participants' motivational styles-an issue of person-situation 'fit' with important effects in public health settings, but which has been ignored in past research.

Primary Outcome

Following each thermal stimulus, participants are asked to rate how painful it was, on a semi-circular computerized scale. Ratings are based on the angle (0-180), with higher angle representing higher pain ratings. We will average and compare the pain ratings within participant across interventions.

Interventions

  • BEHAVIORAL Placebo cream- "promotion" suggestion
  • BEHAVIORAL Placebo cream- "prevention" suggestion
  • BEHAVIORAL Control cream

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-09-30
Est. Completion 2027-12-31
Phase NA
Trustees of Dartmouth College

31 total trials

What is known before NCT04669093 opens enrollment

NCT04669093 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which Placebo cream- "promotion" suggestion is the first listed.

NCT04669093 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04669093 about?

NCT04669093 is a clinical study titled "Individual Differences in Placebo Analgesic Effects". This study examines the effects of placebo suggestions tailored to match or mismatch individual participants' motivational styles-an issue of person-situation 'fit' with important effects in public health settings, but which has been ignored in past research.

What is the current status of trial NCT04669093?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-09-30. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT04669093?

The interventions under investigation include: Placebo cream- "promotion" suggestion (BEHAVIORAL), Placebo cream- "prevention" suggestion (BEHAVIORAL), Control cream (BEHAVIORAL).

Who is sponsoring clinical trial NCT04669093?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04669093's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04669093, the US trial registry maintained by the National Library of Medicine. NCT04669093 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.